Jason Markwell is an accomplished intellectual property litigator.
Jason represents pharmaceutical and biotechnology companies in patent infringement and validity actions, litigation under the Patented Medicines (Notice of Compliance) Regulations, and in disputes relating to data protection, drug approvals, drug pricing and reimbursement, and advertising. Jason has experience in patent cases involving the telecommunications and petroleum industries, and in trademark, copyright and trade secret litigation.
Jason has been recognized as a leading advocate by Chambers and Partners, Lexpert, IAM Patent 1000, Best Lawyers Canada, Who’s Who Legal, and Benchmark Legal. Jason is active in various intellectual property organizations, including the Intellectual Property Institute of Canada and AIPPI, and is a member of the Advocates’ Society.
Jason has appeared before the Supreme Court of Canada, the Federal Court of Appeal, the Federal Court, the Ontario Superior Court, and a number of administrative tribunals. Prior to joining Belmore Neidrauer in 2016, Jason was the Canadian leader of life sciences and healthcare at a global law firm.